We are live on ! Find out more
MDT icon

Medtronic

1,154 hedge funds and large institutions have $62.6B invested in Medtronic in 2014 Q4 according to their latest regulatory filings, with 140 funds opening new positions, 361 increasing their positions, 497 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $976M | Put options by funds: $521M

34% more funds holding in top 10

Funds holding in top 10: 5067 (+17)

32% more first-time investments, than exits

New positions opened: 140 | Existing positions closed: 106

17% more capital invested

Capital invested by funds: $53.3B → $62.6B (+$9.21B)

2% more funds holding

Funds holding: 1,1351,154 (+19)

0.65% more ownership

Funds ownership: 87.8%88.45% (+0.65%)

27% less repeat investments, than reductions

Existing positions increased: 361 | Existing positions reduced: 497

Holders
1,154
Holders Change
+19
Holders Change %
+1.67%
% of All Funds
30.77%
Holding in Top 10
67
Holding in Top 10 Change
+17
Holding in Top 10 Change %
+34%
% of All Funds
1.79%
New
140
Increased
361
Reduced
497
Closed
106
Calls
$976M
Puts
$521M
Net Calls
+$455M
Net Calls Change
+$86.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Fuller & Thaler Asset Management
951
Fuller & Thaler Asset Management
California
$325K +$34.7K +500 +13%
AI
952
Atria Investments
North Carolina
$323K +$20.1K +289 +7%
LOAMS
953
Lombard Odier Asset Management (Switzerland)
Switzerland
$321K -$13.1M -188,758 -98%
LOAME
954
Lombard Odier Asset Management (Europe)
United Kingdom
$321K +$307K +4,417 New
VHAM
955
Van Hulzen Asset Management
California
$317K -$664K -9,556 -69%
SSWM
956
Smith Salley Wealth Management
North Carolina
$316K -$11.9K -171 -4%
Manulife (Manufacturers Life Insurance)
957
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$313K -$4.94M -71,078 -2%
CIM
958
Contravisory Investment Management
Massachusetts
$312K -$86.8K -1,250 -22%
BPC
959
Banque Pictet & Cie
Switzerland
$310K
HIM
960
Hermes Investment Management
United Kingdom
$310K
SIM
961
SSI Investment Management
California
$308K
BMC
962
Benin Management Corp
Connecticut
$307K +$3.47K +50 +1%
CTA
963
Colonial Trust Advisors
South Carolina
$306K -$35.1K -505 -11%
IFB
964
iAB Financial Bank
Indiana
$300K -$3.47K -50 -1%
TAM
965
Tocqueville Asset Management
New York
$300K +$11K +158 +4%
BAM
966
Berkshire Asset Management
Pennsylvania
$299K -$74.7K -1,075 -21%
CCG
967
Cypress Capital Group
Florida
$299K -$48.5K -698 -14%
PFBT
968
Parkside Financial Bank & Trust
Missouri
$297K +$10.2K +147 +4%
PWLP
969
Prio Wealth Limited Partnership
Massachusetts
$297K +$19.1K +275 +7%
QAM
970
Quantres Asset Management
Cayman Islands
$296K -$2.56M -36,900 -90%
WIC
971
Woodmont Investment Counsel
Tennessee
$295K
LYV
972
Live Your Vision
Pennsylvania
$294K
DAM
973
Delta Asset Management
Tennessee
$293K
Grantham, Mayo, Van Otterloo & Co (GMO)
974
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$292K -$38M -546,961 -99%
HS
975
HighVista Strategies
Massachusetts
$291K +$37.5K +540 +15%

MDT Hedge Fund Activity: Q4 2014 in Review

1,154 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2014, worth a combined $62.6B — up 17% from $53.3B a quarter earlier.

Buyers outnumbered sellers: 140 funds opened new MDT positions and 106 closed out — a net gain of 34 holders — while 361 added to existing stakes and 497 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $1.83B. The largest seller was Primecap Management, cutting an estimated $761M.

  • 1,154 institutional investors held Medtronic (MDT) as of Q4 2014, up from 1,135 in Q3 2014.
  • Funds reported $62.6B of Medtronic stock for Q4 2014, up 17% quarter-over-quarter.
  • 140 funds opened new Medtronic positions in Q4 2014 and 106 closed out, a net change of +34 holders.
  • The largest Medtronic buyer in Q4 2014 was Fidelity Investments, an estimated $1.83B added.
  • The largest Medtronic seller in Q4 2014 was Primecap Management, an estimated $761M sold.

Based on aggregated 13F filings for Q4 2014.